Monthly Archives: April 2014

An Update on Masochism

Since NIR’s post on ‘Those who fail to learn from obscenity are condemned to repeat it’, there has been some movement regarding both the overtures made by Valeant to Allergan, and Pfizer to AstraZeneca. 1) Allergan appears to be casting … Continue reading

Posted in Uncategorized | Leave a comment

Those Who Fail to Learn from Obscenity are Condemned to Repeat It

As May approaches, the ‘Street’ has perked up at the news and rumor, respectively,   of two takeover aspirations: Valeant (with Pershing Square Capital) seeking to buy Allergan for $45.6 billion, Pfizer reportedly considering an offer of $101 billion for Astra … Continue reading

Posted in BioFollies, Biotech | Tagged , | 1 Comment

The Porcine Prerogative: A Perilous Precedent

While not falling within the CNS arena per se, the consequences of Gilead Pharma‘s decision to platinum-price Sovaldi for Hepatitis C, to the tune of $84,000 per three month treatment cycle in the US, eventually will permeate health care in … Continue reading

Posted in Big Pharma | Tagged , , , | 24 Comments